Search Results

You are looking at 1 - 10 of 22 items for :

  • Framingham risk score x
  • Life Sciences x
Clear All
Open access

Snežana Jovičić, Svetlana Ignjatović and Nada Majkić-Singh

-10. Conroy RM, Pyorala K, Fitzgerald AP, Sans S, Menotti A, De Backer G, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J. 2003; 24 : 987-1003. National Cholesterol Education Program. Risk assessment tool for estimating 10-year risk of developing hard CHD (myocardial infarction and coronary death). http://hin.nhlb.nih.gov/atpiii/calculator.asp?usertype=prof Topol EJ, Lauer MS. The rudimentary phase of personalised medicine: coronary risk scores. Lancet

Open access

Alin Albai, Mirela Frandeș, Ramona Luminița Sandu, Gabriel Spoială, Flavia Hristodorescu, Bogdan Timar and Romulus Timar

, Fitzgerald AP et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 24: 987-1003, 2003. 6. D’Agostino RB Sr, Vasan RS, Pencina MJ et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 117: 743-753, 2008. 7. Centers for Disease Control and Prevention . National diabetes fact sheet: National estimates and general information on diabetes and prediabetes in the United States, 2011. Atlanta, GA: U.S. Department of Health and Human Services, Centers for

Open access

Snežana Jovičić

inhibits three steps in the formation of mildly oxidized low density lipoprotein. J Lipid Res 2000; 41: 1481-508. Vega GL, Grundy SM. Hypoalphalipoproteinemia (low high density lipoprotein) as a risk factor for coronary heart disease. Curr Opin Lipidol 1996; 7: 209-16. Schaefer EJ, Lamon-Fava S, Ordovas JM, Cohn SD, Schaefer MM, Castelli WP, et al. Factors associated with low and elevated plasma high density lipoprotein cholesterol and apolipoprotein A-I levels in the Framingham Offspring Study. J Lipid Res 1994

Open access

Nevena Eremić and Mirjana Đerić

Cholesterol Education Program Adult Treatment Panel III Guidelines. JACC 2004; 44 (3): 720-32. National Heart Lung and Blood Institute. Framingham Heart Study. http://www.nhlbi.nih.gov/about/framingham/index.html Sarti C, Gallagher J. The metabolic syndrome. J Diabetes Complicat 2006; 20 (2): 121-32. Assman G, Cullen P, Shulte H. Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the Prospective Cardiovascular Munster (PROCAM) study

Open access

Piotr Chmielewski, Bartłomiej Strzelec, Jolanta Chmielowiec, Krzysztof Chmielowiec and Krzysztof Borysławski

. Relationship between serum bilirubin concentration and nondipper hypertension. Int J Clin Exp Med 7:1454-8. Djousse L, Levy D, Cupples LA, Evans JC, D’Agostino RB, Ellison RC. 2001. Total serum bilirubin and risk of cardiovascular disease in the Framingham offspring study. Am J Cardiol 87:1196-200. Erdogan D, Gullu H, Yildirim E, Tok D, Kirbs I, Ciftci O, Baycan ST, Muderrisoglu H. 2006. Low serum bilirubin levels are independently and inversely related to impaired flow-mediated vasodilation and increased carotid intima-media thickness in both

Open access

Maria Kaczmarek and Magdalena Skrzypczak

Among Ache Amerindian Males in Paraguay , Am. J. Phys. Anthropol. , 127 , 114-121 Campbell A., 1976, Subjective Measures of Well-Being , American Psychologist , 2 , 117-124 Chen Y-T., V. Vaccarino, C. S. Williams, J. Butler, L. F. Berkman, H. M. Krumholz, 1999, Risk factors for heart failure in the elderly: a prospective community-based study , American Journal of Medicine , 106 , 605-612 Crawford M. H., 2005, Genetics of biological aging in Mennonotes of Midwestern United States

Open access

Grazyna Sypniewska, Katarzyna Bergmann, Magdalena Krintus, Marek Kozinski and Jacek Kubica

Diabetes Association and the American College of Cardiology Foundation. J Am Coll Cardiol 2008; 51: 1512-24. Kathiresan S, Otvos JD, Sullivan LM, et al. Increased small lowdensity lipoprotein particle number: a prominent feature of the metabolic syndrome in the Framingham Heart Study. Circulation 2006; 113: 20-9. Chan DC, Watts GF. Apolipoproteins as markers and managers of coronary risk. QJM 2006; 99: 277-87. Eremić N, Đerić M. Evaluation of coronary risk score applications in 10-yaer coronary

Open access

Vesna Vuković-Dejanović, Nataša Bogavac-Stanojević, Slavica Spasić, Vesna Spasojević-Kalimanovska, Dimitra Kalimanovska-Oštrić, Mirko Topalović and Zorana Jelić-Ivanović

coronary artery disease by using Framingham Risk Score (FRS). J An Bio-Sci 2011; 34: 324–30. 35. Koenig W, Löwel H, Baumert J, Meisinger C. Baumert and Christa Meisinger. C-Reactive Protein modulates risk prediction based on the Framingham Score: Implications for future risk assessment: Results from a large cohort study in Southern Germany. Circulation 2004; 109: 1349–53. 36. Cristell N, Cianflone D, Durante A, Ammirati E, Vanuzzo D, Banfi M, et al. High-sensitivity C-reactive protein is within normal levels at the very onset of first ST-segment elevation

Open access

Aleksandra Stefanović, Danijela Ristovski-Kornic, Jelena Kotur-Stevuljević, Vesna Spasojević-Kalimanovska, Jelena Vekić, Milica Miljković, Dusan Paripović, Amira Peco-Antic, Zorana Jelić-Ivanović and Aleksandra Zeljković

HDL subclasses and their relationship with Framingham risk score in middle-aged Serbian population. Clin Biochem 2007; 40: 310-6. 16. Mafra D, Guebre-Egziabher F, Fouque D. Body mass index, muscle and fat in chronic kidney disease: questions about survival. Nephrol Dial Transplant 2008; 23: 2461-6. 17. Tsompanidi EM, Brinkmeier MS, Fotiadou EH, Giakoumi SM, Kypreo KE. HDL biogenesis and functions: role of HDL quality and quantity in atherosclerosis. Athero - sclerosis 2010; 208: 3-9. 18. Zeljkovic A, Vekic J

Open access

Bosa Mirjanić-Azarić, Zorana Jelić-Ivanović, Aleksandra Zeljković, Jelena Vekić, Günther Jürgens, Tatjana Milivojac, Sanja Avram, Jozo Ćorić, Janja Marc and Darko Černe

data by quantitative real-time RT PCR. J Med Biochem 2013; 32: 325-38. 16. Rainwater DL, Andres DW, Ford AL, Lowe WF, Blanche PJ, Krauss RM. Production of polyacrylamide gradient gels for the electrophoretic resolution of lipoproteins. J Lipid Res 1992; 33: 1876 81. 17. Vekić J, Topić A, Zeljković A, Jelić-Ivanović Z, Spa - sojević-Kalimanovska V. LDL and HDL subclasses and their relationship with Framingham risk score in middleaged Serbian population. Clin Biochem 2007; 40: 310-6. 18. Zeljković A, Spasojević